COMBINED HIGH-DOSE SUB-TENON TRIAMCINOLONE, INTRAVITREAL BEVACIZUMAB, AND LASER PHOTOCOAGULATION FOR REFRACTORY DIABETIC MACULAR EDEMA
Publication in refereed journal


引用次數
替代計量分析
.

其它資訊
摘要Purpose: To study the efficacy and safety of triple therapy (sub-Tenon triamcinolone [similar to 70 mg], intravitreal bevacizumab [1.25 mg], and focal/grid laser) for refractory diabetic macular edema.
著者Chan CKM, Lai TYY, Mohamed S, Lee VYW, Liu DTL, Li CL, Lam DSC
會議名稱33rd Annual Meeting of the Macula-Society
會議開始日25.02.2010
會議地點Tucson
期刊名稱RETINA
出版年份2012
月份4
日期1
卷號32
期次4
出版社Lippincott, Williams & Wilkins
頁次672 - 678
國際標準期刊號0275-004X
電子國際標準期刊號1539-2864
語言英式英語
關鍵詞bevacizumab; diabetic retinopathy; laser photocoagulation; triamcinolone acetonide
Web of Science 學科類別Ophthalmology; OPHTHALMOLOGY

上次更新時間 2021-12-01 於 23:46